Product Recalls in Mississippi

Product recalls affecting Mississippi — including food, drugs, consumer products, medical devices, and vehicles distributed to Mississippi. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,628 recalls have been distributed to Mississippi in the last 12 months.

49,744 total recalls
2,628 in last 12 months

Showing 64616480 of 13,570 recalls

DrugAugust 21, 2018· Auro Pharmacies, Inc.

Recalled Item: Methyl-Cobalamin injectable Recalled by Auro Pharmacies, Inc. Due to Lack of...

The Issue: Lack of Assurance of Sterility: Inadequate processes and equipment to assure...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 21, 2018· Auro Pharmacies, Inc.

Recalled Item: Calcium Gluconate injectable Recalled by Auro Pharmacies, Inc. Due to Lack...

The Issue: Lack of Assurance of Sterility: Inadequate processes and equipment to assure...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 20, 2018· Hetero Labs Limited Unit V

Recalled Item: Montelukast Sodium Tablets Recalled by Hetero Labs Limited Unit V Due to...

The Issue: Discoloration: A complaint was received from a pharmacist for the presence...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 17, 2018· Torrent Pharma Inc.

Recalled Item: Amlodipine and Valsartan Tablets Recalled by Torrent Pharma Inc. Due to CGMP...

The Issue: CGMP Deviations: Carcinogen impurity detected in API used to manufacture...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 17, 2018· Torrent Pharma Inc.

Recalled Item: Amlodipine Recalled by Torrent Pharma Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Carcinogen impurity detected in API used to manufacture...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 17, 2018· Torrent Pharma Inc.

Recalled Item: Amlodipine Recalled by Torrent Pharma Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Carcinogen impurity detected in API used to manufacture...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 17, 2018· Torrent Pharma Inc.

Recalled Item: Amlodipine and Valsartan Tablets Recalled by Torrent Pharma Inc. Due to CGMP...

The Issue: CGMP Deviations: Carcinogen impurity detected in API used to manufacture...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 17, 2018· Torrent Pharma Inc.

Recalled Item: Valsartan Tablets USP Recalled by Torrent Pharma Inc. Due to CGMP...

The Issue: CGMP Deviations: Carcinogen impurity detected in API used to manufacture...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 17, 2018· Torrent Pharma Inc.

Recalled Item: Amlodipine and Valsartan Tablets Recalled by Torrent Pharma Inc. Due to CGMP...

The Issue: CGMP Deviations: Carcinogen impurity detected in API used to manufacture...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 17, 2018· Torrent Pharma Inc.

Recalled Item: Amlodipine Recalled by Torrent Pharma Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Carcinogen impurity detected in API used to manufacture...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 17, 2018· Torrent Pharma Inc.

Recalled Item: Amlodipine and Valsartan Tablets Recalled by Torrent Pharma Inc. Due to CGMP...

The Issue: CGMP Deviations: Carcinogen impurity detected in API used to manufacture...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 17, 2018· Torrent Pharma Inc.

Recalled Item: Valsartan Tablets USP Recalled by Torrent Pharma Inc. Due to CGMP...

The Issue: CGMP Deviations: Carcinogen impurity detected in API used to manufacture...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 17, 2018· Torrent Pharma Inc.

Recalled Item: Valsartan Tablets USP Recalled by Torrent Pharma Inc. Due to CGMP...

The Issue: CGMP Deviations: Carcinogen impurity detected in API used to manufacture...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 17, 2018· Torrent Pharma Inc.

Recalled Item: Amlodipine Recalled by Torrent Pharma Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Carcinogen impurity detected in API used to manufacture...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 17, 2018· Torrent Pharma Inc.

Recalled Item: Amlodipine Recalled by Torrent Pharma Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Carcinogen impurity detected in API used to manufacture...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 15, 2018· Hetero Labs Limited Unit V

Recalled Item: Montelukast Sodium Tablets 10 mg Recalled by Hetero Labs Limited Unit V Due...

The Issue: Labeling: Label Mix-Up - One lot labeled Montelukast Sodium Tablets 10 mg...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugAugust 14, 2018· Mylan Institutional, Inc. (d.b.a. UDL Laboratories)

Recalled Item: Diltiazem HCl Extended-release Capsules Recalled by Mylan Institutional,...

The Issue: Failed Impurities/Degradation Specifications; out of specification results...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugAugust 14, 2018· AVKARE Inc.

Recalled Item: Valsartan Tablets Recalled by AVKARE Inc. Due to CGMP Deviations: Carcinogen...

The Issue: CGMP Deviations: Carcinogen impurity detected in API used to manufacture...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 14, 2018· AVKARE Inc.

Recalled Item: Valsartan Tablets Recalled by AVKARE Inc. Due to CGMP Deviations: Carcinogen...

The Issue: CGMP Deviations: Carcinogen impurity detected in API used to manufacture...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 14, 2018· Mckesson Corporation

Recalled Item: Megestrol Acetate Oral Suspension Recalled by Mckesson Corporation Due to...

The Issue: Supterpotent Drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund